AOL Television

Analyst Moves: BIIB, CELG

  • Aired: 1/10/2012
    • Length:
    • Plays: ???
Synopsis >

Biogen Idec (BIIB) was downgraded by UBS (UBS) to neutral from buy with a price target of $156, as the firm believes that the stock price has gotten ahead of itself, being higher by about 56% since the last upgrade. Shares are lower by about seven tenths of a percent.

TV GUIDE Users' Most Popular